Important Disclosures

Important Notices: This document does not constitute an offering of any security, product, service, fund, or any other pooled investment vehicle (each, a “Fund”) managed and advised by Proteus, LLC, a Delaware limited liability company (“Proteus”), for which an offer can only be made to qualified investors through a Fund’s Confidential Offering Memorandum (the “Memorandum”) prepared by the Fund. The preceding is only a summary, does not purport to be complete, and is qualified in its entirety by the provisions of the Memorandum and the Fund’s Operating Agreement. As a result, this summary may not contain all of the information you may desire about the Fund or Proteus. This report is not an offer to sell or a solicitation to purchase securities in the Fund; rather it is intended to summarize only the general terms of Proteus and its service offering for informational purposes only. An offer or sale of the interests in a Fund can only take place upon the review of the Memorandum and the execution of a definitive subscription agreement. The purchase of interests in a Fund is suitable only for sophisticated investors for whom an investment in a Fund does not constitute a complete investment program and who fully understand and are willing to assume the risks involved in a Fund’s investment program. The interests of a Fund will not be registered under the laws of any jurisdiction, including the United States Securities Act of 1933, as amended, or the United States Investment Company Act of 1940, as amended, the laws of any state of the United States, or the laws of any foreign jurisdiction, and may not be offered or sold without compliance with applicable securities laws. Hedge funds (or funds of hedge funds) often engage in leveraging and other speculative investment practices that may increase the risk of investment loss; can be highly illiquid; are not required to provide periodic pricing or valuation information to investors (unless otherwise required by the Fund’s organizational documents); may involve complex tax structures and delays in distributing important tax information; are not subject to the same regulatory requirements as registered investment companies; and often charge high fees. An investor could lose all or substantially all of his, her, or its investment. Where securities are issued in a currency other than the investor’s currency of reference, changes in exchange rates may have an adverse effect on the value of the investment. Further, any number of conflicts of interest may exist in the context of the management and operation of any hedge fund. No securities commission or similar authority in the United States or Canada has reviewed this report or in any way passed upon its merits, and any representation to the contrary is an offense. Canadian investors may be subject to “hold periods” of indefinite duration pursuant to applicable securities laws.

Additional Information

No investment may be solicited, considered, affirmed, or completed unless pursuant to the Memorandum and the execution of a definitive subscription agreement. Such documentation will contain full details of the offering of a Fund’s interests and the Fund’s investment strategy. A Fund will not accept any funds from a potential investor solely as a result of a review of this document, and any unsolicited funds will be returned. You should assume that the information contained in this report is accurate only as of the date hereof. The delivery of this report is for informational purposes only and shall not be deemed an offer to sell Fund interests or a solicitation of an offer to buy Fund interests.

Historical and Simulated Performance

Certain performance and statistical data information presented may represent simulated and/or historical performance. This data is no guarantee of future performance and may not represent actual performance of an investment product based on the index or the funds referenced and has not been audited. Actual investment results may differ. Simulated returns may not reflect the impact that material economic and market factors might have had on the advisor’s decision making if the advisor were actually managing clients’ money. Simulated data is subject to the fact that it is designed with the benefit of hindsight. Simulated returns carry the risk that the performance depicted is not due to successful predictive modeling. Simulated nor historical returns cannot predict how an investment strategy will perform in the future and are not considered indicative of the skill of the advisor. Investors may experience loss.

Forward-Looking Statements

This report may contain certain statements regarding Proteus, the Funds, and their future anticipated results, performance, and achievements. These “forward-looking” statements are based on the beliefs of, assumptions made by, and information available to Proteus. Where possible, this report uses words such as “may,” “will,” “believes,” “anticipates,” “intends,” “estimates,” “expects,” “plans,” and similar expressions to identify these forward-looking statements. Proteus and the Funds are subject to various substantial risks, uncertainties, and other factors that could cause their actual results, performance, and achievements to differ materially from those expressed in, or implied by, these statements.

Benchmark Definitions

S&P LSTA US Leveraged Loan Index is designed to reflect the performance of the largest facilities in the leveraged loan market.

Multi Strategy Credit represents the total strategy in the market prepared by eVestment and its affiliated entities (collectively, “eVestment”). EVestment collects information directly from investment management firms and other sources believed to be reliable; however, eVestment does not guarantee or warrant the accuracy, timeliness, or completeness of the information provided and is not responsible for any errors or omissions.

Risk-free rate being used is the FTSE 3 Month US T Bill Index.

For Further Information, Interested Parties May Contact:

Proteus, LLC

Attention: Investor Relations

8900 Keystone Crossing, Suite 500

Indianapolis, Indiana 46240

investorrelations@proteuscapital.us